After all these years, it was surprising when we heard the FDA on the news today, all of a sudden make a big announcement against the use of Aspirin
for health benefits
Yes, many know people know of the warnings for possible stomach bleeding but a light dose--81 mg-- was always regarded as okay, as long as approved by
the doctor or if one was responsible enough to watch for any signs of bleeding
Until Bayer merged with Merck
And now Bayer wants to push their new drug, Adempas-- which has only been out since last year-- and they are going to co-develop more heart drugs with
An Aspirin a Day? Don't Dose Yourself,
That’s the reminder Monday from health officials at the federal Food and Drug Administration, who have finally told giant drugmaker Bayer
Corp. not to expect the agency to give the go-ahead for labels listing aspirin as a drug for primary prevention of heart attacks and other problems.
Instead, the recommendation for daily doses of therapeutic aspirin remains the same: It should be used only in people at high risk for heart attack
and stroke, and then only under a doctor’s care.
“You should use daily aspirin therapy only after first talking to your health care professional, who can weigh the risks and benefits,” said Dr.
Robert Temple, the FDA’s deputy director for clinical science.
Now then, tests regarding Aspirin has been going on since 2003, so why now is the FDA speaking out about it?
Maybe, because of the merger, their plans to develop expensive heart drugs are on top of their 'To Do' list
Bayer Bulks Up Its Medicine Chest With Merck Brands
Merck MRK -2.59% & Co. is getting out of the business of making Claritin allergy medicines and Coppertone sunscreens, selling off its
over-the-counter business to Bayer AG BAYN.XE -0.93% for $14.2 billion.
Tuesday's deal is just the latest in a wave of mergers and acquisitions that is reshaping the global pharmaceutical industry. Many drug companies are
narrowing their focus, dropping out of noncore businesses and bulking up where they have the size and expertise to generate significant sales
Call me suspicious but what are the odds of the FDA on Monday stating not to rely on Bayer Aspirin after all these years--remember we have always been
warned of possible stomach bleeding-- and then this announcement today of the merger
One thing pops into my mind....more money can be made if they push for a prescription drug for heart problems and get people to ease off OTC Aspirins
that would be cheaper, with less side effects
Merck and Bayer also agreed to form a collaboration to co-develop and market certain prescription heart drugs, including Bayer's Adempas, a
treatment for a form of high blood pressure. Merck will pay Bayer $1 billion upfront, plus potential additional milestone payments of up to $1.2
billion if sales goals are reached.
Now then, while doing a search on Adempas --no generic available-- the cost is staggering!!!!!!!!
I'm finding that it can cost approx. $2694 or more a month....
Compared to a $4 bottle of 81 mg Aspirin....albeit not a guarantee to fix heart problems
No wonder they are trying to turn the public off of Aspirin after all these years
Maybe it's just me, reading more into it than there needs to be
Or maybe I just don't trust pharmaceutical companies and their greedy ways
Just do your own reading/research, see what you think
edit on 6-5-2014 by snarky412 because: (no reason given)